Luisa Freyer

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

All-Cause Mortality Up to 20 Years After PCI or CABG for Left Main Disease.

All-Cause Mortality Up to 20 Years After PCI or CABG for Left Main Disease.

Journal: Journal of the American College of Cardiology

Published: July 14, 2026

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Journal: Nature medicine

Published: July 02, 2026

Sex-specific differences in the prognostic value of ischemic pre-hospital ECGs.

Sex-specific differences in the prognostic value of ischemic pre-hospital ECGs.

Journal: Frontiers in cardiovascular medicine

Published: April 04, 2026

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 30, 2026

Relevance of supraventricular ectopy in predicting atrial fibrillation after embolic stroke of undetermined source.

Relevance of supraventricular ectopy in predicting atrial fibrillation after embolic stroke of undetermined source.

Journal: International journal of cardiology. Heart & vasculature

Published: December 04, 2025

Does Digital Screening for Atrial Fibrillation Reach its Target Group?: Insights From the eBRAVE-AF Trial.

Does Digital Screening for Atrial Fibrillation Reach its Target Group?: Insights From the eBRAVE-AF Trial.

Journal: JACC. Advances

Published: June 10, 2025

Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

Gender specific aspects of digital screening for atrial fibrillation: insights from the randomized eBRAVE-AF trial.

Journal: European heart journal. Digital health

Published: January 30, 2025

Cardiac autonomic function score: a novel risk stratification tool in the cardiac intensive care unit based on periodic repolarization dynamics and deceleration capacity of heart rate (LMU-eICU study).

Cardiac autonomic function score: a novel risk stratification tool in the cardiac intensive care unit based on periodic repolarization dynamics and deceleration capacity of heart rate (LMU-eICU study).

Journal: European heart journal. Digital health

Published: January 07, 2025

Traditional and advanced electrocardiographic measures of autonomic function in the population-based KORA-F3 study.

Traditional and advanced electrocardiographic measures of autonomic function in the population-based KORA-F3 study.

Journal: European journal of epidemiology

Published: December 31, 2024

Impact of Age on Smartphone-Based Screening for Atrial Fibrillation: A Prespecified Subgroup Analysis of the eBRAVE-AF Trial.

Impact of Age on Smartphone-Based Screening for Atrial Fibrillation: A Prespecified Subgroup Analysis of the eBRAVE-AF Trial.

Journal: Circulation. Arrhythmia and electrophysiology

Published: December 11, 2024

Connecting the dots: spots on the skin, weakness within.

Connecting the dots: spots on the skin, weakness within.

Journal: Infection

Published: January 17, 2024

Periodic repolarization dynamics: Different methods for quantifying low-frequency oscillations of repolarization.

Periodic repolarization dynamics: Different methods for quantifying low-frequency oscillations of repolarization.

Journal: Journal of electrocardiology

Published: June 15, 2023

Showing 1-12 of 14

Last Updated: 09/26/2026